Revealing the pathogenesis of the 5q-syndrome

[1] PROPOSALS FOR THE CLASSIFICATION OF THE MYELODYSPLASTIC SYNDROMES [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) : 189 - 199

[2] BOULTWOOD J, 1994, BLOOD, V84, P3253

[3] Narrowing and genomic annotation of the commonly deleted region of the 5q-syndrome [J]. BLOOD, 2002, 99 (12) : 4638 - 4641

[4] Brunning RD, 2001, WHO CLASSIFICATION T, P62

[5] Identification of RPS14 as a 5q- syndrome gene by RNA interference screen [J]. NATURE, 2008, 451 (7176) : 335 - U7

[6] Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies [J]. CLINICAL CANCER RESEARCH, 2006, 12 (01) : 5 - 10

[7] International scoring system for evaluating prognosis in myelodysplastic syndromes [J]. BLOOD, 1997, 89 (06) : 2079 - 2088

[8] New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes:: evidence from a core dataset of 2124 patients [J]. BLOOD, 2007, 110 (13) : 4385 - 4395

[9] Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders [J]. BLOOD, 2007, 110 (02) : 719 - 726

[10] Efficacy of lenalidomide in myelodysplastic syndromes [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (06) : 549 - 557

[1] PROPOSALS FOR THE CLASSIFICATION OF THE MYELODYSPLASTIC SYNDROMES [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) : 189 - 199

[2] BOULTWOOD J, 1994, BLOOD, V84, P3253

[3] Narrowing and genomic annotation of the commonly deleted region of the 5q-syndrome [J]. BLOOD, 2002, 99 (12) : 4638 - 4641

[4] Brunning RD, 2001, WHO CLASSIFICATION T, P62

[5] Identification of RPS14 as a 5q- syndrome gene by RNA interference screen [J]. NATURE, 2008, 451 (7176) : 335 - U7

[6] Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies [J]. CLINICAL CANCER RESEARCH, 2006, 12 (01) : 5 - 10

[7] International scoring system for evaluating prognosis in myelodysplastic syndromes [J]. BLOOD, 1997, 89 (06) : 2079 - 2088

[8] New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes:: evidence from a core dataset of 2124 patients [J]. BLOOD, 2007, 110 (13) : 4385 - 4395

[9] Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders [J]. BLOOD, 2007, 110 (02) : 719 - 726

[10] Efficacy of lenalidomide in myelodysplastic syndromes [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (06) : 549 - 557